Despite convincing data and undoubted advantages, use of PDE inhibitors in ARDS is lower than they deserve, likely due to rare or missing clinical studies on the use of nonselective and selective PDEs in the treatment of ARDS or sepsis. The gene discussed is ALDH7A1; the disease is Sepsis.